Novavax, Inc. (NVAX) Reports In-Line Q2 EPS

Novavax, Inc. (NASDAQ: NVAX) reported Q2 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $7.1 million versus the consensus estimate of $6.68 million.

For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Kepler Cheuvreux Downgrades Carl Zeiss Meditec AG (AFXG:GR) (CZMWY) to Reduce
• HSBC Upgrades Pegatron Corp. (4938:TT) to Hold